Second-generation ampakine that potentiates AMPA receptor function (EC50 value 14 µM for increase of glutamate-induced steady state currents) and enhances glutamatergic synaptic transmission, demonstrating improved cognitive performance in a variety of tasks. CX691 aka Farampator is developed primarily as a putative antipsychotic.

KEYWORDS: Farampator | supplier | AMPA PAM | CX691 | Org24448 | CX-691 | CX 691 | Org-24448 | Org 24448 | CAS [211735-76-1] | Glutamate | positive allosteric modulator | Ion Channel | cognitive | putative antipsychotic | ampakine | memory | Alzheimer | CNS